CTRI/2017/10/010299
Recruiting
未知
Evaluation of a novel device for monitoring of asthma status in symptomatic patients when treated for one month with inhaled corticosteroids.
Redecol Limited0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Redecol Limited
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female patients aged 18 to 80 years
- •2\. Steroid naïve patients (not taken steroids for 28 days)
- •3\. Patients presenting to the chest clinic
- •4\. Patients able to read and understand the Patient Information Leaflet and Consent Form.
- •5\. Patients able to provide deep inhaled breaths and exhale while holding a tube in their mouth.
- •6\. Patients who will be available for subsequent diagnostic tests to be conducted within 30 days of the first visit to the chest clinic.
- •7\. Patients with a normal Chest X\-Ray
Exclusion Criteria
- •1\. Patients who have taken steroid medication in the previous 28 days.
- •2\. Patients with chest infection or other known lung disease in the previous one month.
- •3\. Patients who have taken a short\-acting beta 2\-agonists in the previous 8 hours, (before baseline test).
- •4\.Patients who have taken Ipratropium bromide in the previous 24 hours, (before baseline test).
- •5\.Patients with no clinically significant haematology, biochemistry or urinalysis results, (before baseline test).
- •6\. Patients who have taken Long\-acting beta 2\-agonists in the previous 24 hours, (before baseline test).
- •7\. Patients who have taken leukotriene antagonist in the previous 28 days, (before baseline test).
- •8\. Patients who are too unwell to participate in this study e.g. emergency patients, (before baseline test).
- •9\.Participants who, in the opinion of the Investigator, will not be able to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of a New Novel Fluid Monitoring Device in Heart Failure PatientsCongestive heart failure (CHF)Cardiovascular - Other cardiovascular diseasesACTRN12619000960156Safehouse Innovation Ltd20
Recruiting
Not Applicable
The evaluation of new device for self measuring of intraocular pressureGlaucoma, heathy volunteersJPRN-UMIN000006947Division of Surgery, Department of Ophthalmology, Kobe University Graduate School of Medicine40
Completed
Not Applicable
The Aspirometer: A Noninvasive Tool for Detecting Aspiration Aim 3Deglutition DisordersNCT06637774University of Pittsburgh50
Completed
Not Applicable
Validation of novel inspection method detecting autofluorescence from eyecataract with diabetic retinopathy, cataract without diabetic retinopathyJPRN-UMIN000011110Department of Ophthalmology, Tohoku University Graduate School of Medicine120
Completed
Not Applicable
Evaluation of minimally invasive monitoring system for postprandial hyperglycemiaJPRN-UMIN000004274Osaka University School of Medicine50